[1]CurrentPatentAssignee:BALTICGRUPPENBIO;BETAGENONAB;CARLINGDAVIDANDREW-WO2021/74646,2021,A1Locationinpatent:Page/Pagecolumn24
[1]CurrentPatentAssignee:BALTICGRUPPENBIO;BETAGENONAB;CARLINGDAVIDANDREW-WO2021/74646,2021,A1Locationinpatent:Page/Pagecolumn25
[1]CurrentPatentAssignee:BALTICGRUPPENBIO;BETAGENONAB-WO2022/153042,2022,A1Locationinpatent:Page/Pagecolumn25-26
[1]CurrentPatentAssignee:BETAGENONBIO-WO2023/31609,2023,A1
Title: Periodic Reporting for period 1-AMPK-DIAB (A small molecule AMP activated protein kinase (AMPK) activator, denoted O304, as a novelinnovative drug for the treatment of type 2 diabetes).